Minimal residual disease in hematological malignancies

[1] Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program [J]. LEUKEMIA, 2003, 17 (12) : 2474 - 2486

[2] CROSS NCP, 1993, BLOOD, V82, P1929

[3] Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR [J]. LEUKEMIA, 1999, 13 (11) : 1825 - 1832

[4] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J]. LEUKEMIA, 2003, 17 (12) : 2318 - 2357

[5] Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients [J]. LEUKEMIA, 2002, 16 (12) : 2447 - 2453

[6] Hochhaus A, 2000, BLOOD, V95, P62

[7] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) : 1423 - 1432

[8] EARLY DETECTION OF RELAPSE AFTER BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA [J]. LANCET, 1993, 341 (8840) : 275 - 276

[9] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C [J]. LEUKEMIA, 2003, 17 (12) : 2392 - 2400

[10] Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization [J]. LEUKEMIA, 2002, 16 (12) : 2395 - 2399

[1] Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program [J]. LEUKEMIA, 2003, 17 (12) : 2474 - 2486

[2] CROSS NCP, 1993, BLOOD, V82, P1929

[3] Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR [J]. LEUKEMIA, 1999, 13 (11) : 1825 - 1832

[4] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J]. LEUKEMIA, 2003, 17 (12) : 2318 - 2357

[5] Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients [J]. LEUKEMIA, 2002, 16 (12) : 2447 - 2453

[6] Hochhaus A, 2000, BLOOD, V95, P62

[7] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) : 1423 - 1432

[8] EARLY DETECTION OF RELAPSE AFTER BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA [J]. LANCET, 1993, 341 (8840) : 275 - 276

[9] Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C [J]. LEUKEMIA, 2003, 17 (12) : 2392 - 2400

[10] Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization [J]. LEUKEMIA, 2002, 16 (12) : 2395 - 2399